PIK3CA Mutation trials recruiting in Colorado
Fewer than 3 recruiting trials found.
All PIK3CA Mutation trials nationally
2
Recruiting in Colorado
2
Cities with sites
Cities in Colorado
Denver 1Longmont 1
Recruiting trials in Colorado
- First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer